Hyliion Q2 revenue $1.5M; cuts FY 2025 rev guidance to $5-10M on KARNO delay to 2026

Hyliion Holdings Corp.

2025-Q2 EPS reported -$0.18 vs consensus -$0.09 ▼ miss (-96.1%)

Net loss of $13.4M in Q2 2025 vs $10.9M a year ago; cash and investments $185.3M at quarter-end.
Revised 2025 revenue guidance to $5-10M from $10-15M; commercialization of KARNO product delayed to 2026.
KARNO Power Module qualifies for 30% ITC under OBBBA; signed $1B MOU with Alkhorayef for Saudi deployment.
Resolved regen depowdering challenge; transitioned LEM production in-house to support 2025 Early Adopter units.
Expects year-end cash ~$155M; targets breakeven cash gross margins by end of 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.